Direct Intra-Patient Comparison of Scaffold Protein-Based Tracers, [(99m)Tc]Tc-ADAPT6 and [(99m)Tc]Tc-(HE)(3)-G3, for Imaging of HER2-Positive Breast Cancer

SIMPLE SUMMARY: The receptor HER2 is overexpressed in some breast cancers. Tumours with a high HER2 expression can be successfully treated with the antibodies trastuzumab and pertuzumab. The radionuclide imaging of HER2 in disseminated cancer could help to select patients for treatment using these a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bragina, Olga, Chernov, Vladimir, Schulga, Alexey, Konovalova, Elena, Hober, Sophia, Deyev, Sergey, Sörensen, Jens, Tolmachev, Vladimir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296685/
https://www.ncbi.nlm.nih.gov/pubmed/37370758
http://dx.doi.org/10.3390/cancers15123149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296685/
https://www.ncbi.nlm.nih.gov/pubmed/37370758
http://dx.doi.org/10.3390/cancers15123149

Ejemplares similares